Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abuse Potential of Neurontin (Gabapentin) in Recreational Users
NCT04570436Phase 4Completed
- Sponsor
- Viatris
- Start
- Mar 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gabapentin in postherpetic neuralgia (PHN), epilepsy, sponsored by Viatris. Started Mar 2021; status: completed.
02
Drugs
gabapentin
03
Conditions
postherpetic neuralgia (PHN)epilepsy
Beyond the preview
Go deeper on NCT04570436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04570436.